U.S. federal trademark · Serial No. 86582465 · Reg. No. 5788015
Pharmaceuticals used to prevent disease in the nature of cancer, cancer symptoms, cancer-related diseases and side effects of cancer therapies; pharmaceuticals used to treat and cure neoplastic conditions, pre-neoplastic conditions and disrupted microbial community associated with aforementioned conditions in human and animal subjects; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of neoplastic conditions, pre-neoplastic conditions and disrupted microbial community associated with the aforementioned conditions; live bacteria, inactivated bacteria, recombinant bacteria and bacterial extracts; biological preparations in the nature of microorganisms to prevent disease in the nature of neoplastic conditions and pre-neoplastic conditions in animal or human subjects; biological preparations in the nature of microorganisms to treat and cure neoplastic conditions and pre-neoplastic conditions in animal or human subjects; biological preparations in the nature of microorganisms to maintain and restore health in animal or human subjects via treatment of neoplastic conditions and pre-neoplastic conditions; cultures of microorganisms and preparation of microorganisms in the nature of bacterial and bacteriological preparations, all for medical and veterinary purposes, the foregoing for medical purposes
Medical research; research and development in the pharmaceutical and biotechnology fields
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.